The medical beauty sector is stronger again, and aimike is reaching a new high

Synthetic Biology: Who Will Emerge as the Winner?

The 21st century is the century of biology. Synthetic biology is believed to be a ‘World Changing’ industry. But the potential risks like cost control and commercialization pathways are fatefully tied to the ups and downs of countless investment decisions and the destiny of the many new start-ups getting involved. We look forward to seeing an emerging ‘giant’ on the horizon of this exciting industry.

WaveFront Ventures: How Can Chinese Companies Win the Global Robotic Race

Here we present an exclusive interview with Ken Li, founder of WaveFront. Ken shared his insights into WaveFront's investment vision and strategies for Chinese companies going overseas.

CRM Software Provider EC Nets more than 100 Mn in Series D2

Business services are quietly changing. In the past, traditional CRM vendors have never been able to solve the problems of high costs of home-grown PaaS, long delivery cycles, and uncontrollable projects in the face of personalised enterprise needs. The new model of combining SaaS+PaaS will enable SaaS vendors to break out of the customisation trap.

CIRCUE: AI Drives the Revolution of Energy, Leading a Sustainable Future

Increasing numbers of industrial and commercial businesses are embracing green practices in a big way. Based on AI, IoT (Internet of Things), and big data applications, Chinese energy AI technology companies with advanced cutting-edge technology have considered or tried to enter the oversea market. Zheng yu Chu, founder and chief executive officer of the a battery AI technology company CIRCUE, has shared his views from technology, business to globalization in this interview.

Bloomage: Injecting Biotechnology into Beauty Care

Listed on the Chinese Star Market in November 2019, Bloomage was trading at CNY 138.01 as of June 24, 2020, over 38% higher than the IPO price of CNY 100.